Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pietro Invernizzi

Showing results (161-170 of 420) with videos related to

Pageof 42
Sort By:
Cellular & Molecular Immunology|December 24, 2009
Experimental evidence on the immunopathogenesis of primary biliary cirrhosisCarlo Selmi, Francesca Meda, Anaid Kasangian, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 8, 2020
Reduction and stabilization of bilirubin with obeticholic acid treatment in patients with primary biliary cholangitisAlbert Parés, Mitchell Shiffman, Victor Vargas, et al.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|November 19, 2003
T-cell receptor polymorphism in primary biliary cirrhosisCarlo Selmi, Pietro Invernizzi, Pasquale Tripputi, et al.
Autoimmunity Reviews|December 26, 2012
Infectome: a platform to trace infectious triggers of autoimmunityDimitrios P Bogdanos, Daniel S Smyk, Pietro Invernizzi, et al.
Pediatric Blood & Cancer|January 1, 2020
Hepatic focal nodular hyperplasia after pediatric hematopoietic stem cell transplantation: The impact of hormonal replacement therapy and iron overloadAlessandro Cattoni, Attilio Rovelli, Giulia Prunotto, et al.
International Journal of Molecular Sciences|May 14, 2022
The Role of Epigenetics in Primary Biliary CholangitisAlessio Gerussi, Elvezia Maria Paraboschi, Claudio Cappadona, et al.
Hepatology Communications|February 22, 2023
Impact of setanaxib on quality of life outcomes in primary biliary cholangitis in a phase 2 randomized controlled trialDavid Jones, Marco Carbone, Pietro Invernizzi, et al.
Surgical Oncology|September 3, 2020
Gastro-entero-pancreatic neuroendocrine neoplasia: The rules for non-operative managementFrancesco Panzuto, Sara Massironi, Stefano Partelli, et al.
Clinical and Translational Gastroenterology|March 17, 2017
Human β-Defensin 2 in Primary Sclerosing CholangitisCindy Chang, Ana Lleo, Anchasa Kananurak, et al.
Alimentary Pharmacology & Therapeutics|May 4, 2022
Systematic review-pancreatic involvement in inflammatory bowel diseaseSara Massironi, Ilaria Fanetti, Chiara Viganò, et al.
Pageof 42

Showing results (161-170 of 420) with videos related to

Sort By:
Pageof 42
Cellular & Molecular Immunology|December 24, 2009
Experimental evidence on the immunopathogenesis of primary biliary cirrhosisCarlo Selmi, Francesca Meda, Anaid Kasangian, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 8, 2020
Reduction and stabilization of bilirubin with obeticholic acid treatment in patients with primary biliary cholangitisAlbert Parés, Mitchell Shiffman, Victor Vargas, et al.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|November 19, 2003
T-cell receptor polymorphism in primary biliary cirrhosisCarlo Selmi, Pietro Invernizzi, Pasquale Tripputi, et al.
Autoimmunity Reviews|December 26, 2012
Infectome: a platform to trace infectious triggers of autoimmunityDimitrios P Bogdanos, Daniel S Smyk, Pietro Invernizzi, et al.
Pediatric Blood & Cancer|January 1, 2020
Hepatic focal nodular hyperplasia after pediatric hematopoietic stem cell transplantation: The impact of hormonal replacement therapy and iron overloadAlessandro Cattoni, Attilio Rovelli, Giulia Prunotto, et al.
International Journal of Molecular Sciences|May 14, 2022
The Role of Epigenetics in Primary Biliary CholangitisAlessio Gerussi, Elvezia Maria Paraboschi, Claudio Cappadona, et al.
Hepatology Communications|February 22, 2023
Impact of setanaxib on quality of life outcomes in primary biliary cholangitis in a phase 2 randomized controlled trialDavid Jones, Marco Carbone, Pietro Invernizzi, et al.
Surgical Oncology|September 3, 2020
Gastro-entero-pancreatic neuroendocrine neoplasia: The rules for non-operative managementFrancesco Panzuto, Sara Massironi, Stefano Partelli, et al.
Clinical and Translational Gastroenterology|March 17, 2017
Human β-Defensin 2 in Primary Sclerosing CholangitisCindy Chang, Ana Lleo, Anchasa Kananurak, et al.
Alimentary Pharmacology & Therapeutics|May 4, 2022
Systematic review-pancreatic involvement in inflammatory bowel diseaseSara Massironi, Ilaria Fanetti, Chiara Viganò, et al.
Pageof 42